<Anchor>



It has been confirmed that the Korean government, which has signed a corona19 vaccine contract with 4 pharmaceutical companies so far, is also ahead of a contract with the US company NovaVax.



Last-minute negotiations to secure more than 10 million people are currently underway, and reporter Nam Joo-hyun will tell you why the government is trying to increase the amount and type of vaccines.



<Reporter> The



current corona19 vaccine secured by the government is the 56 million people promised by four pharmaceutical companies and Cobax facilities.



We are negotiating with Nova Bax to secure an additional supply for 10 million people.



At the end of the contract, at least 66 million people will be secured, which is 14 million more than the entire nation.



The government's judgment is to seek a stable supply of vaccines by increasing the amount introduced.



If the vaccination plan is delayed, the case of discarding the vaccine as in foreign countries may occur.



Even if you get the vaccine, you will need more vaccines if the duration of your immunity is shorter than expected.



[Jeong Eun-kyung/Director of the Korea Disease Control Center (Yesterday): There is such uncertainty about how long the immunity will last, additional vaccinations, re-vaccinations, and how much these parts will be needed, and issues remain in such areas as supply or permission...

.] The



composition of various vaccine products can reduce uncertainty.



This is because the development period for the COVID-19 vaccine was short, and both RNA vaccines and carrier vaccines are new methods.



We cannot guarantee that not all vaccines will have side effects or will produce the expected effect.



NovaVax is currently undergoing phase 3 clinical trials in the US, and is expected to end as soon as possible within the first quarter.



[Geun-Hwa Lee/Professor, Department of Microbiology, Hanyang University School of Medicine: A vaccine that combines a viral antigen and an adjuvant (immune adjuvant) can be considered safe because it is a method used to make a vaccine.]



Unlike Pfizer, Moder, or vaccines, 2 degrees Celsius The advantage of NovaVax vaccine is that it can be distributed and stored at ~8 degrees.



(Video editing: Kim Jong-mi)